Expression of drugable targets in pediatric malignancies: Innovative therapies for children with cancer

被引：0
|
作者：
Verschuur, A. C.
Versteeg, R.
Vassal, G.
Pieters, R.
Delattre, O.
Serra, M.
Pritchard-Jones, K.
Shipley, J.
Clifford, S.
Pietsch, T.
Geoerger, B.
Lanvers, C.
den Boer, M.
Caron, H.
机构：
[1] Emma Childrens Hosp AMC, Amsterdam, Netherlands
[2] Inst Gustave Roussy, F-94800 Villejuif, France
[3] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
[4] Inst Curie, F-75005 Paris, France
[5] Inst Ortoped Rizzoli, Bologna, Italy
[6] Inst Canc Res, Sutton SM2 5NG, Surrey, England
[7] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[8] Univ Bonn, D-5300 Bonn, Germany
[9] Univ Klinikum Munster, Munster, Germany
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [31] Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies
    Lesniak, Maria
    Lipniarska, Justyna
    Majka, Patrycja
    Lejman, Monika
    Zawitkowska, Joanna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [32] Molecular Targets and Therapies for Ampullary Cancer
    Patel, Monica Arun
    Kratz, Jeremy D.
    Carlson, Alexander S.
    Ascencio, Ysaith Orellana
    Kelley, Broc S.
    Loconte, Noelle K.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D):
  • [33] Epigenetic targets in hematological malignancies: Combination therapies with HDACis and demethylating agents
    Bishton, Mark
    Kenealy, Melita
    Johnstone, Ricky
    Rasheed, Walid
    Prince, H. Miles
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1439 - 1449
  • [34] USE OF SUPPORTIVE CARE THERAPIES AMONG PEDIATRIC CANCER PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING CHEMOTHERAPY.
    Constance, J.
    Stockmann, C.
    Linakis, M.
    Balch, A.
    Korgenski, K.
    Spraker-Perlman, H.
    Lemons, R.
    Sherwin, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S10 - S10
  • [35] USE OF SUPPORTIVE CARE THERAPIES AMONG PEDIATRIC CANCER PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING CHEMOTHERAPY.
    Constance, J.
    Stockmann, C.
    Linakis, M.
    Balch, A.
    Korgenski, K.
    Spraker-Perlman, H.
    Lemons, R.
    Sherwin, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S90 - S90
  • [36] Use of alternative therapies for children with cancer, compared with a general pediatric population 652
    Tracey Friedman
    William B Slayton
    Linda S. Allen
    Brad H. Pollock
    Marilyn Dumont Driscoll
    Paulette Mehta
    John Graham-Pole
    [J]. Pediatric Research, 1997, 41 (Suppl 4) : 111 - 111
  • [37] Immunotherapy targets in pediatric cancer
    Orentas, Rimas J.
    Lee, Daniel W.
    Mackall, Crystal
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [38] Editorial: Innovative therapies and novel challenges in pediatric intestinal failure
    Koglmeier, Jutta
    De Koning, Barbara
    Norsa, Lorenzo
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [39] NEW DRUG DEVELOPMENT FOR CHILDREN WITH BRAIN TUMOURS: THE EXPERIENCE OF THE EUROPEAN CONSORTIUM FOR INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC)
    Vassal, G.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II41 - II41
  • [40] Innovative cancer therapies Putting Costs Into Context
    Khayat, David
    [J]. CANCER, 2012, 118 (09) : 2367 - 2371
12345